Sign in

CIK 0001335105

  • Non-accelerated filer
  • Smaller reporting company

NOMAD POWER SOLUTIONS, INC.

Sign in to watch
Ticker
NMAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202903526
Phone
+1 310-203-2902
Business address
433 PLAZA REAL, SUITE 275, BOCA RATON, FL, 33432
Former names
LIXTE BIOTECHNOLOGY HOLDINGS, INC., SRKP 7 INC
  1. 4 Open-market buy Director bought 52,632 shares at $4.75 ($250,002)
  2. 4 Open-market buy 10% owner bought 52,632 shares at $4.75 ($250,002)
  3. 4 Open-market buy Director bought 21,053 shares at $4.75 ($100,002)
  4. 4 Open-market buy Director bought 21,053 shares at $4.75 ($100,002)
  5. 4 Open-market buy President and CEO bought 21,100 shares at $4.75 ($100,225)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy 10% owner bought 1,040,000 shares at $0.50 ($520,000)
  8. 4 Open-market buy Director bought 100,000 shares at $0.50 ($50,000)
  9. 4 Open-market buy Director bought 100,000 shares at $0.50 ($50,000)
  10. 4 Open-market buy 10% owner bought 1,260,000 shares at $0.50 ($630,000)
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy 10% owner bought 1,005,556 shares at $0.06 ($59,328)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy 10% owner bought 53,500 shares at an average $0.30 ($15,963)
  19. 4 Open-market buy 10% owner bought 2,500 shares at $0.25 ($625)
  20. 4 Derivatives Options or other derivatives

Page 6 of 7 · 138 filings